The effect of stroke on immune function

Molecular and Cellular Neuroscience

Volumn 53, Issue , 2013, Pages 26-33

  Brambilla, Roberta ^a   Couch, Yvonne ^b   Lambertsen, Kate Lykke ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Autonomic nervous system; HPA axis; Immune responses; Stroke

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUTAMIC ACID;

ARTICLE; BRAIN INFECTION; BRAIN ISCHEMIA; CELL FUNCTION; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; LEUKOPENIA; NATURAL KILLER T CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CYTOKINES; HUMANS; INFECTION; INFLAMMATION; SIGNAL TRANSDUCTION; STROKE;

EID: 84873282117     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.08.011     Document Type: Article

References (113)

1. Ajmo C.T., Vernon D.O., Collier L., Hall A.A., Garbuzova-Davis S., Willing A., Pennypacker K.R. The spleen contributes to stroke-induced neurodegeneration. J. Neurosci. Res. 2008, 86:2227-2234.
2. Ajmo C.T., Collier L.A., Leonardo C.C., Hall A.A., Green S.M., Womble T.A., Cuevas J., Willing A.E., Pennypacker K.R. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp. Neurol. 2009, 218:47-55.
3. Anne M., Juha K., Timo M., Mikko T., Olli V., Kyosti S., Heikki H., Vilho M. Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality. Curr. Neurovasc. Res. 2007, 4:170-175.
4. Aslanyan S., Weir C.J., Diener H.C., Kaste M., Lees K.R. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur. J. Neurol. 2004, 11:49-53.
5. Astrup J., Siesjo B.K., Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981, 12:723-725.
6. Bao Y., Kim E., Bhosle S., Mehta H., Cho S. A role for spleen monocytes in post-ischemic brain inflammation and injury. J. Neuroinflammation 2010, 7:92.
7. Becker K.J., Kindrick D.L., Lester M.P., Shea C., Ye Z.C. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J. Cereb. Blood Flow Metab. 2005, 25:1634-1644.
8. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., Sacks D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
9. Blond D., Campbell S.J., Butchart A.G., Perry V.H., Anthony D.C. Differential induction of interleukin-1beta and tumour necrosis factor-alpha may account for specific patterns of leukocyte recruitment in the brain. Brain Res. 2002, 958:89-99.
10. Bornstein N.M., Aronovich B., Korczyn A.D., Shavit S., Michaelson D.M., Chapman J. Antibodies to brain antigens following stroke. Neurology 2001, 56:529-530.
11. Borovikova L.V., Ivanova S., Nardi D., Zhang M., Yang H., Ombrellino M., Tracey K.J. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 2000, 85:141-147.
12. Bowes M.P., Zivin J.A., Rothlein R. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Model. 1993, 119:215-219.
13. Campbell S.J., Deacon R.M., Jiang Y., Ferrari C., Pitossi F.J., Anthony D.C. Overexpression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour. Neurobiol. Dis. 2007, 27:151-163.
14. Chamorro A., Horcajada J.P., Obach V., Vargas M., Revilla M., Torres F., Cervera A., Planas A.M., Mensa J. The early systemic prophylaxis of infection after stroke study: a randomized clinical trial. Stroke 2005, 36:1495-1500.
15. Chamorro A., Urra X., Planas A.M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007, 38:1097-1103.
16. Chapman K.Z., Dale V.Q., Denes A., Bennett G., Rothwell N.J., Allan S.M., McColl B.W. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J. Cereb. Blood Flow Metab. 2009, 29:1764-1768.
17. Chen H., Chopp M., Zhang R.L., Bodzin G., Chen Q., Rusche J.R., Todd R.F. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 1994, 35:447-452.
18. Chen H., Chopp M., Zhang R.L., Bodzin G., Chen Q., Rusche J.R., Todd R.F. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 1994, 35:458-463.
19. Chopp M., Zhang R.L., Chen H., Li Y., Jiang N., Rusche J.R. Post ischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Stroke 1994, 25:869-876.
20. Clark W.M., Madden K.P., Rothlein R., Zivin J.A. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. 1991, 75:623-627.
21. Clark W.M., Madden K.P., Rothlein R., Zivin J.A. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 1991, 22:877-883.
22. Clausen B.H., Lambertsen K.L., Meldgaard M., Finsen B. A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 2005, 132:879-892.
23. Colivicchi F., Bassi A., Santini M., Caltagirone C. Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement. Stroke 2004, 35:2094-2098.
24. Czech B., Pfeilschifter W., Mazaheri-Omrani N., Strobel M.A., Kahles T., Neumann-Haefelin T., Rami A., Huwiler A., Pfeilschifter J. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem. Biophys. Res. Commun. 2009, 389:251-256.
25. Czlonkowska A., Cyrta B., Korlak J. Immunological observations on patients with acute cerebral vascular disease. J. Neurol. Sci. 1979, 43:455-464.
26. Dambinova S.A., Khounteev G.A., Izykenova G.A., Zavolokov I.G., Ilyukhina A.Y., Skoromets A.A. Blood test detecting autoantibodies to N-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 2003, 49:1752-1762.
27. del Zoppo G.J., Sharp F.R., Heiss W.D., Albers G.W. Heterogeneity in the penumbra. J. Cereb. Blood Flow Metab. 2011, 31:1836-1851.
28. Dirnagl U., Klehmet J., Braun J.S., Harms H., Meisel C., Ziemssen T., Prass K., Meisel A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007, 38:770-773.
29. Egea J., Rosa A.O., Sobrado M., Gandia L., Lopez M.G., Garcia A.G. Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice. Neuroscience 2007, 145:866-872.
30. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
31. Emsley H.C., Smith C.J., Tyrrell P.J., Hopkins S.J. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit. Care 2008, 9:125-138.
32. Enlimomab Acute Stroke Trial Investigators Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 2001, 57:1428-1434.
33. Fagan S.C., Waller J.L., Nichols F.T., Edwards D.J., Pettigrew L.C., Clark W.M., Hall C.E., Switzer J.A., Ergul A., Hess D.C. Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke 2010, 41:2283-2287.
34. Feinstein D.L., Heneka M.T., Gavrilyuk V., Dello Russo C., Weinberg G., Galea E. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem. Int. 2002, 41:357-365.
35. Franceschini R., Gandolfo C., Cataldi A., Del Sette M., Cianciosi P., Finocchi C., Rolandi E., Barreca T. Twenty-four-hour beta-endorphin secretory pattern in stroke patients. Stroke 1994, 25:2142-2145.
36. Fujii Y.X., Fujigaya H., Moriwaki Y., Misawa H., Kasahara T., Grando S.A., Kawashima K. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. J. Neuroimmunol. 2007, 189:69-74.
37. Galea E., Heneka M.T., Dello Russo C., Feinstein D.L. Intrinsic regulation of brain inflammatory responses. Cell. Mol. Neurobiol. 2003, 23:625-635.
38. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.U., Siler D.A., Arumugam T.V., Orthey E., Gerloff C., Tolosa E., Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
39. Gendron A., Teitelbaum J., Cossette C., Nuara S., Dumont M., Geadah D., du Souich P., Kouassi E. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res. 2002, 955:85-97.
40. Haddad J.J., Saade N.E., Safieh-Garabedian B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J. Neuroimmunol. 2002, 133:1-19.
41. Haeusler K.G., Schmidt W.U., Fohring F., Meisel C., Helms T., Jungehulsing G.J., Nolte C.H., Schmolke K., Wegner B., Meisel A., Dirnagl U., Villringer A., Volk H.D. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc. Dis. 2008, 25:50-58.
42. Hankey G.J. Recurrent stroke rate was higher than coronary heart disease rate in the first year after stroke but similar after the first year. ACP J. Club 2006, 144:50.
43. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 2006, 6:508-519.
44. Harms H., Prass K., Meisel C., Klehmet J., Rogge W., Drenckhahn C., Gohler J., Bereswill S., Gobel U., Wernecke K.D., Wolf T., Arnold G., Halle E., Volk H.D., Dirnagl U., Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008, 3:e2158.
45. Hayakawa K., Mishima K., Nozako M., Hazekawa M., Mishima S., Fujioka M., Orito K., Egashira N., Iwasaki K., Fujiwara M. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 2008, 39:951-958.
46. Heijnen C.J. Receptor regulation in neuroendocrine-immune communication: current knowledge and future perspectives. Brain Behav. Immun. 2007, 21:1-8.
47. Hewlett K.A., Corbett D. Delayed minocycline treatment reduces long-term functional deficits and histological injury in a rodent model of focal ischemia. Neuroscience 2006, 141:27-33.
48. Hiramoto T., Chida Y., Sonoda J., Yoshihara K., Sudo N., Kubo C. The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor. Gastroenterology 2008, 134:2122-2131.
49. Hossmann K.A. Pathophysiology and therapy of experimental stroke. Cell. Mol. Neurobiol. 2006, 26:1057-1083.
50. Hug A., Dalpke A., Wieczorek N., Giese T., Lorenz A., Auffarth G., Liesz A., Veltkamp R. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 2009, 40:3226-3232.
51. Hug A., Liesz A., Muerle B., Zhou W., Ehrenheim J., Lorenz A., Dalpke A., Veltkamp R. Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke 2011, 42:3580-3586.
52. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
53. Izci Y. Splenectomy may be a prophylactic treatment for cerebral ischemia?. Med. Hypotheses 2010, 75:347-349.
54. Jauch E.C., Lindsell C., Broderick J., Fagan S.C., Tilley B.C., Levine S.R. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006, 37:2508-2513.
55. Jiang N., Zhang R.L., Chen H., Chopp M. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient (2h) but not after permanent MCA occlusion in the rat. Neurosci. Res. Commun. 1994, 15:85-94.
56. Jiang N., Moyle M., Soule H.R., Rote W.E., Chopp M. Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann. Neurol. 1995, 38(6):935-942.
57. Johnston K.C., Li J.Y., Lyden P.D., Hanson S.K., Feasby T.E., Adams R.J., Faught R.E., Haley E.C. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998, 29:447-453.
58. Katzan I.L., Cebul R.D., Husak S.H., Dawson N.V., Baker D.W. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003, 60:620-625.
59. Kohm A.P., Sanders V.M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 2001, 53:487-525.
60. Krugers H.J., Knollema S., Kemper R.H., Ter Horst G.J., Korf J. Down-regulation of the hypothalamo-pituitary-adrenal axis reduces brain damage and number of seizures following hypoxia/ischaemia in rats. Brain Res. 1995, 690:41-47.
61. Lambertsen K.L., Biber K., Finsen B. Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood Flow Metab. 2012, 32:1677-1698.
62. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
63. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79:1431-1568.
64. Liu Z., Fan Y., Won S.J., Neumann M., Hu D., Zhou L., Weinstein P.R., Liu J. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007, 38:146-152.
65. Mackroth M.S., Malhotra I., Mungai P., Koech D., Muchiri E., King C.L. Human cord blood CD4+CD25hi regulatory T cells suppress prenatally acquired T cell responses to Plasmodium falciparum antigens. J. Immunol. 2011, 186:2780-2791.
66. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 2008, 29:117-124.
67. Manoonkitiwongsa P.S., Jackson-Friedman C., McMillan P.J., Schultz R.L., Lyden P.D. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J. Cereb. Blood Flow Metab. 2001, 21:1223-1231.
68. Marrif H., Juurlink B.H. Astrocytes respond to hypoxia by increasing glycolytic capacity. J. Neurosci. Res. 1999, 57:255-260.
69. Marsh B.J., Williams-Karnesky R.L., Stenzel-Poore M.P. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 2009, 158:1007-1020.
70. Marz P., Cheng J.G., Gadient R.A., Patterson P.H., Stoyan T., Otten U., Rose-John S. Sympathetic neurons can produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:3251-3256.
71. Matsushita T., Horikawa M., Iwata Y., Tedder T.F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 2010, 185:2240-2252.
72. McColl B.W., Allan S.M., Rothwell N.J. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 2009, 158:1049-1061.
73. McQuillan J.A., Mitchell A.J., Ho Y.F., Combes V., Ball H.J., Golenser J., Grau G.E., Hunt N.H. Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria. Int. J. Parasitol. 2011, 41:155-163.
74. Mergenthaler P., Dirnagl U., Meisel A. Pathophysiology of stroke: lessons from animal models. Metab. Brain Dis. 2004, 19:151-167.
75. Mfonkeu J.B., Gouado I., Kuate H.F., Zambou O., Combes V., Grau G.E., Zollo P.H. Biochemical markers of nutritional status and childhood malaria severity in Cameroon. Br. J. Nutr. 2010, 104:886-892.
76. Mirabelli-Badenier M., Braunersreuther V., Viviani G.L., Dallegri F., Quercioli A., Veneselli E., Mach F., Montecucco F. CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb. Haemost. 2011, 105:409-420.
77. Newberry R.D. Intestinal lymphoid tissues: is variety an asset or a liability?. Curr. Opin. Gastroenterol. 2008, 24:121-128.
78. Newcomb J.D., Ajmo C.T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006, 15:213-223.
79. Nilupul Perera M., Ma H.K., Arakawa S., Howells D.W., Markus R., Rowe C.C., Donnan G.A. Inflammation following stroke. J. Clin. Neurosci. 2006, 13:1-8.
80. Offner H., Subramanian S., Parker S.M., Afentoulis M.E., Vandenbark A.A., Hurn P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 2006, 26:654-665.
81. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Lewis A., Vandenbark A.A., Hurn P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 2006, 176:6523-6531.
82. Offner H., Vandenbark A.A., Hurn P.D. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009, 158:1098-1111.
83. Oto J., Suzue A., Inui D., Fukuta Y., Hosotsubo K., Torii M., Nagahiro S., Nishimura M. Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients. J. Anesth. 2008, 22:207-212.
84. Ottani A., Giuliani D., Mioni C., Galantucci M., Minutoli L., Bitto A., Altavilla D., Zaffe D., Botticelli A.R., Squadrito F., Guarini S. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J. Cereb. Blood Flow Metab. 2009, 29:512-523.
85. Pankoui Mfonkeu J.B., Gouado I., Fotso Kuate H., Zambou O., Amvam Zollo P.H., Grau G.E., Combes V. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 2010, 5:e13415.
86. Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009, 8:1006-1018.
87. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003, 198:725-736.
88. Ren X., Akiyoshi K., Dziennis S., Vandenbark A.A., Herson P.S., Hurn P.D., Offner H. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci. 2011, 31:8556-8563.
89. Rodriguez-Yanez M., Davalos A., Castillo J. Withdrawal from statins: implications for secondary stroke prevention and acute treatment. Int. J. Stroke 2008, 3:85-87.
90. Ryan K.J., Griffin E.W., Connor T.J. Complementary anti-inflammatory actions of the beta-adrenoceptor agonist clenbuterol and the glucocorticoid dexamethasone in rat brain. J. Neuroimmunol. 2011, 232:209-216.
91. Savitz S.I., Erhardt J.A., Anthony J.V., Gupta G., Li X., Barone F.C., Rosenbaum D.M. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J. Cereb. Blood Flow Metab. 2000, 20:1197-1204.
92. Schulte-Herbruggen O., Quarcoo D., Meisel A., Meisel C. Differential affection of intestinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodulation 2009, 16:213-218.
93. Schwarz S., Al-Shajlawi F., Sick C., Meairs S., Hennerici M.G. Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). Stroke 2008, 39:1220-1227.
94. Shimizu J., Yamazaki S., Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 1999, 163:5211-5218.
95. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A.A., Sanberg P.R., Tan J. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 2004, 89:337-343.
96. Stevens R.D., Nyquist P.A. The systemic implications of aneurysmal subarachnoid hemorrhage. J. Neurol. Sci. 2007, 261:143-156.
97. Tang Y., Xu H., Du X., Lit L., Walker W., Lu A., Ran R., Gregg J.P., Reilly M., Pancioli A., Khoury J.C., Sauerbeck L.R., Carrozzella J.A., Spilker J., Clark J., Wagner K.R., Jauch E.C., Chang D.J., Verro P., Broderick J.P., Sharp F.R. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J. Cereb. Blood Flow Metab. 2006, 26:1089-1102.
98. Tascilar N., Irkorucu O., Tascilar O., Comert F., Eroglu O., Bahadir B., Cakmak G.K., Ankarali H., Sayan H. Bacterial translocation in experimental stroke: what happens to the gut barrier?. Bratisl. Lek. Listy 2010, 111:194-199.
99. Tokgozoglu S.L., Batur M.K., Topuoglu M.A., Saribas O., Kes S., Oto A. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 1999, 30:1307-1311.
100. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999, 79:1-71.
101. Uehara A., Gottschall P.E., Dahl R.R., Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology 1987, 121:1580-1582.
102. Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K.R., Zigova T., Sanberg C.D., Sanberg P.R., Willing A.E. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004, 35:2390-2395.
103. Vermeij F.H., Scholte op Reimer W.J., de Man P., van Oostenbrugge R.J., Franke C.L., de Jong G., de Kort P.L., Dippel D.W. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc. Dis. 2009, 27:465-471.
104. Vogelgesang A., May V.E., Grunwald U., Bakkeboe M., Langner S., Wallaschofski H., Kessler C., Broker B.M., Dressel A. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One 2010, 5:e8718.
105. Westendorp W.F., Nederkoorn P.J., Vermeij J.D., Dijkgraaf M.G., van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011, 11:110.
106. Williams J.B., Jauch E.C., Lindsell C.J., Campos B. Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. Acad. Emerg. Med. 2007, 14:685-690.
107. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., Glockner F., Lanksch W.R., Volk H.D., Docke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 1998, 4:808-813.
108. Woiciechowsky C., Schoning B., Lanksch W.R., Volk H.D., Docke W.D. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J. Mol. Med. (Berl.) 1999, 77:769-780.
109. Wong C.H., Jenne C.N., Lee W.Y., Leger C., Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011, 334:101-105.
110. Young J.B., Fish S., Landsberg L. Sympathetic nervous system and adrenal medullary responses to ischemic injury in mice. Am. J. Physiol. 1983, 245:E67-E73.
111. Zemke D., Majid A. The potential of minocycline for neuroprotection in human neurologic disease. Clin. Neuropharmacol. 2004, 27:293-298.
112. Zhang R.L., Chopp M., Jiang N., Tang W.X., Prostak J., Manning A.M. Anti-ICAM-1 antibody reduces ischemic cell damage after transient but not permanent MCA occlusion in the Wistar rat. Stroke 1995, 26:1438-1443.
113. Zhang Z.G., Chopp M., Tang W.X., Jiang N., Zhang R.L. Post-ischemic treatment (24h) with anti-CDllb and anti-CD18 monoclonal antibodies are neuroprotective after transient (2h) focal cerebral ischemia in the rat. Brain Res. 1995, 698:79-85.